Nursing Expert Presented Prostate Cancer Care Guide
Clinical nurse specialist Frank dela Rama outlined critical screening and risk factors for prostate cancer.
Updated on Sept. 22, 2026 in Cancer
Live Poll
Do you plan to discuss family history with your doctor to guide your cancer screening schedule?
Clinical nurse specialist Frank dela Rama presented a comprehensive guide on prostate cancer nursing care at the ONS Bridge 2026 conference. The presentation emphasized the importance of early detection through screening for patients with high-risk factors.
Why it matters
Early detection and risk assessment are vital for improving outcomes, especially for individuals with a family history or specific inherited genetic markers. Targeted screening allows for proactive management of the disease in high-risk populations.
Localized prostate cancer has a 5-year survival rate of nearly 100%, compared to approximately 38% for distant-stage cases. While the average risk is 12% for men with no family history, those with first-degree relatives have more than double the risk.
The players
Frank dela Rama
He is a clinical nurse specialist who presented new guidelines for prostate cancer care at a national oncology conference.
Sutter Health Medical Foundation
Based in Palo Alto, this organization provides extensive medical services and is affiliated with the nursing expertise shared at the conference.
The details
Screening protocols involve prostate-specific antigen blood tests and digital rectal exams to identify potential issues. Risk stratification is determined by evaluating PSA levels, tumor stage, Gleason Grade Group, and biopsy results alongside genetic testing for genes like BRCA1 and BRCA2.
Timeline
Frank dela Rama presented at ONS Bridge 2026 from September 15-16, 2026.
This report was published on September 22, 2026.
Health Landscape
The clinical guidance presented at ONS Bridge 2026 reflects a shift toward highly personalized oncology care that prioritizes genetic risk factors. This approach mirrors the protocols established in the NCCN Guidelines for Prostate Cancer to standardize risk-based screening strategies.
Patients over 65 should consult their doctors about regular PSA testing and digital rectal exams to ensure early detection. Understanding one's family medical history is essential for determining if additional genetic testing for specific risk markers is required.
The takeaway
Prostate cancer remains highly treatable when detected early, especially for those in high-risk categories. Residents in Palo Alto are encouraged to maintain routine check-ups to track personal risk factors as they age.
Further reading
For more information on current treatment standards, visit the Cancer section.
Source note: This article includes information reported by Oncology Nurse Advisor.
Live Poll
Do you plan to discuss family history with your doctor to guide your cancer screening schedule?
